Effectiveness of Low Dose Rasburicase in Prevention and Treatment of Adult Tumour Lysis Syndrome: A Case Series Study

Journal Title: GUJARAT CANCER SOCIETY RESEARCH JOURNAL - Year 2014, Vol 16, Issue 1

Abstract

Rasburicase, a recombinant urate oxidase product, is safe and effective in lowering serum uric acid. A schedule of rasburicase at a dose of 0.15-0.2 mg/kg given once daily intravenously for 5-7 days has been recommended in patients at risk of tumor lysis syndrome, but successful treatment with shorter duration of use has also been reported. The treatment is highly effective, but the cost of Rs 15,000 per 1.5 mg vial is very expensive. In year 2012 total four patients were treated with rasburicase at GCRI with a single dose of rasburicase prior to the initiation of chemotherapy, and the subsequent doses omitted as long as the serum urate levels remained below the upper limit of normal. Three of them died due to severe infection but there was drastic fall in serum uric acid even after single low dose of rasburicase, none requiring dialysis without any added drug related complication.

Authors and Affiliations

Vikas Gadhvi, Apurva Patel, Asha Anand, shailesh Talati, Sandip Shah, Harsha Panchal, Sonia Parikh

Keywords

Related Articles

Minimal Residual Disease Detection in Splenic Marginal Zone Lymphoma by Flow Cytometry and Cytogenetic Techniques

Splenic marginal zone lymphoma (SMZL) is rare indolent B-cell lymphoma and affects elderly people. As a rare disease, with no randomized prospective trials, there is no standard of care for SMZL so far. Spleenectomy has...

Pattern of Head and Neck Cancers in Regional Cancer Centre, Gujarat

The overall aim of this retrospective study was to describe the pattern of head and neck cancers registered at The Gujarat Cancer and Research Institute (GCRI), Regional Cancer Center (RCC) from January 2001 to December...

Department of Nuclear Medicine

The department of Nuclear Medicine at Gujarat Cancer and research Institute, Hospital is committed to improving health through excellence in patient care, research and education. Based on the knowledge about functions of...

Spirituality and Attitude of the Medical Profession

How often are you faced with a situation where your patient equates you with God while thanking you. In India this situation is not rare. It is an embarrassing situation for most, irritating for some due to the over exag...

Expression of RARβ Gene in Invasive Ductal Carcinoma of Breast

Signalling through RARβ plays an important role in breast carcinogenesis. A growing body of evidence supports the hypothesis that RARβ gene is a tumor suppressor gene and chemo preventive effect of retinoids are due to i...

Download PDF file
  • EP ID EP204975
  • DOI -
  • Views 44
  • Downloads 0

How To Cite

Vikas Gadhvi, Apurva Patel, Asha Anand, shailesh Talati, Sandip Shah, Harsha Panchal, Sonia Parikh (2014). Effectiveness of Low Dose Rasburicase in Prevention and Treatment of Adult Tumour Lysis Syndrome: A Case Series Study. GUJARAT CANCER SOCIETY RESEARCH JOURNAL, 16(1), 38-41. https://europub.co.uk/articles/-A-204975